Login / Signup

Patch/plaque mycosis-fungoides-like presentations of DUSP22-translocated T-cell lymphomas.

John S RungeMadison L NoviceNaomi BrionesKiyanna WilliamsLori LoweDaniel F BoyerRyan A WilcoxTrilokraj TejasviAlexandra C Hristov
Published in: Journal of cutaneous pathology (2021)
The DUSP22-IRF4 gene rearrangement results in downregulation of DUSP22, a presumed tumor suppressor in T-cell lymphomagenesis. It has been described in some cases of primary cutaneous and systemic anaplastic large-cell lymphoma, lymphomatoid papulosis, and transformed mycosis fungoides. Here we describe two patients with clinical lesions resembling patch/plaque mycosis fungoides that did not meet WHO criteria for large-cell transformation on histopathology yet showed a DUSP22 translocation. One patient who had a history of systemic anaplastic large-cell lymphoma with DUSP22 translocation presented with cutaneous involvement by his systemic lymphoma along with lymphomatoid papulosis and mycosis-fungoides-like lesions, all showing an identical immunophenotype and T-cell clone. These cases expand the spectrum of DUSP22-rearranged lymphomas to include mycosis-fungoides-like presentations without large-cell transformation.
Keyphrases
  • single cell
  • cell therapy
  • diffuse large b cell lymphoma
  • gene expression
  • stem cells
  • case report
  • mesenchymal stem cells